Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (381)	1/7/1999 12:56:00 PM
From: scaram(o)uche	Respond to of 1073

Steve: >> Rick, you mentioned that "their" management is different and that "their" burn rate is high, but I am unsure whether you were talking about CRGN or GLGC. If you were talking about CRGN (which I think you were), could you expand a little about their management? << Correct, CRGN. Founders, including current CEO, President and Chairman of the Board (Jonathan Rothberg), didn't shave yet when company opened doors. Rothberg and Went (recently departed) were both 27. One usually looks for relevant pharma or biotech experience in your biotech execs, correct? Rothberg was a postdoc for the first two years at CRGN. Rick Rick